← Back
$LIXT All transactions

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

A

$ Value

$0

Shares

50,000

Price

$0

Filed

Sep 4

Insider

Name

Stazzone Peter

Title

Chief Financial Officer

CIK

0002083297

Roles

Officer

Transaction Details

Transaction Date

2025-09-01

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

50,000

Footnotes

Effective September 1, 2025, the reporting person was granted stock options to purchase 50,000 shares vesting vesting 25% on September 1,2025, 25% on December 15,2025, 25% on March 15,2026, and 25% on June 15,2026., subject to continuous service and acceleration upon the occurrence of certain events. The grant was in connection with the reporting person being appointed as the Company's Chief Financial Officer. The exercise price is $4.45 per share.

Filing Info

Accession No.

0001641172-25-026560

Form Type

4

Issuer CIK

0001335105

Stazzone Peter's History

Date Ticker Type Value
2026-04-15 LIXT A
2026-04-15 LIXT D
2025-09-01 LIXT A $0

Other Insiders at LIXT (90d)

Insider Bought Sold Last
Felix Lourdes 2026-04-15
Pursglove Geordan Garrett
CEO and Chairman of the Board
2026-04-15
Sawyer Jason David 2026-04-15
Holloway Michael Andrew 2026-04-15
Stazzone Peter
Chief Financial Officer
2026-04-15
Primus Guy Warren 2026-04-15